-
1 Comment
Ventas, Inc is currently in a long term uptrend where the price is trading 12.5% above its 200 day moving average.
From a valuation standpoint, the stock is 45.5% cheaper than other stocks from the Real Estate sector with a price to sales ratio of 5.4.
Ventas, Inc's total revenue sank by 6.7% to $928M since the same quarter in the previous year.
Its net income has dropped by 99.0% to $112K since the same quarter in the previous year.
Finally, its free cash flow fell by 202.3% to $-309M since the same quarter in the previous year.
Based on the above factors, Ventas, Inc gets an overall score of 2/5.
Industry | REIT-Healthcare Facilities |
---|---|
Sector | Real Estate |
Exchange | NYSE |
CurrencyCode | USD |
ISIN | US92276F1003 |
Dividend Yield | 4.1% |
---|---|
Target Price | 52.59 |
PE Ratio | None |
Market Cap | 17B |
Beta | 1.22 |
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries " healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for VTR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024